Revenue
$190.4M
Net Income
$20.9M
▲ 111.9% YoY
EPS
$0.39
▲ 108.9% YoY
Cash
$70.1M
▼ 20.3% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Manning Meredith Chief Commercial Officer | Sell | Mar 27, 2026 | 4.9K | $30.04 | $146K | Form 4 ↗ |
Manning Meredith Chief Commercial Officer | Sell | Mar 27, 2026 | 2.1K | $31.04 | $65K | Form 4 ↗ |
Manning Meredith Chief Commercial Officer | Sell | Mar 27, 2026 | 558 | $31.72 | $18K | Form 4 ↗ |
Huang Michael F. Sr. VP of Clinical Development | Sell | Mar 27, 2026 | 4.3K | $30.04 | $128K | Form 4 ↗ |
Huang Michael F. Sr. VP of Clinical Development | Sell | Mar 27, 2026 | 1.8K | $31.04 | $57K | Form 4 ↗ |
Huang Michael F. Sr. VP of Clinical Development | Sell | Mar 27, 2026 | 488 | $31.72 | $15K | Form 4 ↗ |
Fulk Jennifer CHIEF FINANCIAL OFFICER | Grant | Mar 2, 2026 | 39.2K | $0.00 | $0 | Form 4 ↗ |